The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands
- 25 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 36 (9), 723-731
- https://doi.org/10.1007/s40264-013-0079-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Healthcare Professionals’ Self-Reported Experiences and Preferences Related to Direct Healthcare Professional CommunicationsDrug Safety, 2012
- Impact of FDA Drug Risk Communications on Health Care Utilization and Health BehaviorsMedical Care, 2012
- Impact of Safety-Related Regulatory Action on Clinical PracticeDrug Safety, 2012
- Impact of Safety-Related Regulatory Action on Drug Use in Ambulatory Care in the NetherlandsClinical Pharmacology & Therapeutics, 2012
- Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administrationEuropean Journal of Clinical Pharmacology, 2011
- Drug Safety Information Through the InternetDrug Safety, 2009
- Drug-risk communication to pharmacists: Assessing the impact of risk-minimization strategies on the practice of pharmacyJournal of the American Pharmacists Association, 2008
- Communicating drug risk to physicians: Challenges and opportunitiesInternational Journal of Risk & Safety in Medicine, 2008
- From best evidence to best practice: effective implementation of change in patients' careThe Lancet, 2003
- Repetition of highly similar messages and attitude change.Journal of Applied Psychology, 1974